CBMG insider filings
Cellular Biomedicine Group, Inc. — 9 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-02-19. Screen CBMG transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CBMG between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Cellular Biomedicine Group, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-02-19 | 4 | Au Chun Kwok Alan — Director | Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 5,056 (derivative) · Disposition to issuer (D): 2,060 (derivative) · Disposition to issuer (D): 9,789 (derivative) · Disposition to issuer (D): 12,056 (derivative) · Disposition to issuer (D): 7,213 (derivative) · +3 more | EDGAR |
| 2021-02-19 | 4 | Ji Gang Jacky — Director | Disposition to issuer (D): 3,620 (derivative) · Disposition to issuer (D): 4,926 (derivative) · Disposition to issuer (D): 2,947 (derivative) · Disposition to issuer (D): 3,133 (derivative) · Disposition to issuer (D): 5,543 (derivative) | EDGAR |
| 2021-02-19 | 4 | Belmont Terry — Director | Disposition to issuer (D): 3,000 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 8,761 (derivative) · Disposition to issuer (D): 11,895 (derivative) · Disposition to issuer (D): 14,648 (derivative) · Disposition to issuer (D): 8,765 (derivative) · +2 more | EDGAR |
| 2021-02-19 | 4 | Zhou Hansheng — Director | Disposition to issuer (D): 5,300 (derivative) · Disposition to issuer (D): 12,056 (derivative) · Disposition to issuer (D): 7,213 (derivative) · Disposition to issuer (D): 6,019 (derivative) · Disposition to issuer (D): 6,976 (derivative) | EDGAR |
| 2021-02-19 | 4 | Liu Wen Tao — Director | Disposition to issuer (D): 213,076 · Disposition to issuer (D): 146,667 (derivative) · Disposition to issuer (D): 5,477 (derivative) · Disposition to issuer (D): 6,348 (derivative) | EDGAR |
| 2021-02-19 | 4 | Yao Yihong — Chief Scientific Officer | Grant/award (A): 54,000 @ $0 · Other (J): 88,549 · Disposition to issuer (D): 18,900 · Other (J): 25,000 (derivative) · Other (J): 10,000 (derivative) · Other (J): 26,500 (derivative) | EDGAR |
| 2021-02-19 | 4 | Chan Andrew K — Ch Legal Ofr, Corp Dev & Sec | Grant/award (A): 48,000 @ $0 · Disposition to issuer (D): 239,747 · Disposition to issuer (D): 38,880 (derivative) · Disposition to issuer (D): 37,904 (derivative) · Other (J): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +1 more | EDGAR |
| 2021-02-19 | 4 | Liu Tony — CEO, CFO, Director | Grant/award (A): 240,000 @ $0 · Other (J): 476,817 · Disposition to issuer (D): 10,700 · Other (J): 5,300 (derivative) · Other (J): 255,000 (derivative) · Other (J): 15,000 (derivative) · +6 more | EDGAR |
| 2021-02-19 | 4 | Schafer Edward T — Director | Disposition to issuer (D): 5,044 (derivative) · Disposition to issuer (D): 4,983 (derivative) | EDGAR |
Recent 8-K events — Cellular Biomedicine Group, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-02-19 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-01-29 | 8-K | 8.01 — Other Events | EDGAR |
| 2020-12-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-10-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-08-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-08-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CBMG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs